Continuous daily use of cilostazol prevents in-stent restenosis following carotid artery stenting: serial angiographic investigation of 229 lesions.

about

Calcification in original plaque and restenosis following carotid artery stenting.Reply to the Letter to the Editor entitled "Determinants of In-stent Restenosis After Carotid Artery Stenting".

P2860

Q47107962-8FC1FE5E-FF96-4D54-9084-269F4E5DC48A Q51605955-0F5435DE-7B5F-492D-94BA-F687960839B5

P2860

Continuous daily use of cilostazol prevents in-stent restenosis following carotid artery stenting: serial angiographic investigation of 229 lesions.

Item

http://www.wikidata.org/entity/Q40268195

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Continuous daily use of cilost ...... investigation of 229 lesions.

@en

type

Item

label

Continuous daily use of cilost ...... investigation of 229 lesions.

@en

prefLabel

Continuous daily use of cilost ...... investigation of 229 lesions.

@en

P1476

Continuous daily use of cilost ...... investigation of 229 lesions.

@en

P2093

Kazuhiro Yoshioka

http://www.w3.org/2001/XMLSchema#string

Shigen Kasakura

http://www.w3.org/2001/XMLSchema#string

Takahisa Mori

http://www.w3.org/2001/XMLSchema#string

Tomonori Iwata

http://www.w3.org/2001/XMLSchema#string

Yoshinori Aoyagi

http://www.w3.org/2001/XMLSchema#string

Yuhei Tanno

http://www.w3.org/2001/XMLSchema#string

Yuichi Miyazaki

http://www.w3.org/2001/XMLSchema#string

P2860

The benefits of combined anti-platelet treatment in carotid artery stenting

Coronary stent restenosis in patients treated with cilostazol

Cilostazol, an inhibitor of type 3 phosphodiesterase, produces endothelium-independent vasodilation in pressurized rabbit cerebral penetrating arterioles

Dual antiplatelet regime versus acetyl-acetic acid for carotid artery stenting

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

ACCF/SCAI/SVMB/SIR/ASITN 2007 clinical expert consensus document on carotid stenting: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents (ACCF/SCAI/SVMB/SIR/ASITN Clinical Expert Consensus Doc

Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial

Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial.

Meta-analysis of randomized controlled trials on effect of cilostazol on restenosis rates and outcomes after percutaneous coronary intervention.

2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi

P304

471-475

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/NEURINTSURG-2014-011565

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25829365

http://www.w3.org/2001/XMLSchema#string

P921

angiography

Continuous daily use of cilostazol prevents in-stent restenosis following carotid artery stenting: serial angiographic investigation of 229 lesions.

about

P2860

P2860

Continuous daily use of cilostazol prevents in-stent restenosis following carotid artery stenting: serial angiographic investigation of 229 lesions.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921